CD8A and acute respiratory distress syndrome: In summary, as shown in Figure 10, we suggest that catechins could be available candidate drugs to meet the requirements, including (1) the direct inhibiting SARS-CoV replication, (2) the enhancement of CD8+ mediated adaptive immunity, (3) the decrease of cytokine storm, and (4) the promoting autophagy-dependent protective mechanism to ameliorate ALI.